Silence Therapeutics Plc ADR (NASDAQ: SLN) is -60.10% lower on its value in year-to-date trading and has touched a low of $6.31 and a high of $27.72 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The SLN stock was last observed hovering at around $6.97 in the last trading session, with the day’s loss setting it -0.04%.
Currently trading at $6.93, the stock is -55.83% and -60.05% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.33 million and changing -0.57% at the moment leaves the stock -65.44% off its SMA200. SLN registered -30.07% loss for a year compared to 6-month loss of -70.16%. The firm has a 50-day simple moving average (SMA 50) of $17.58 and a 200-day simple moving average (SMA200) of $20.121225.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -61.50% gain in the last 1 month and extending the period to 3 months gives it a -55.38%, and is -54.53% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 28.65% over the week and 10.05% over the month.
Silence Therapeutics Plc ADR (SLN) has around 109 employees, a market worth around $327.17M and $20.57M in sales. Profit margin for the company is -364.60%. Distance from 52-week low is 9.83% and -75.00% from its 52-week high. The company has generated returns on investments over the last 12 months (-59.17%).
The EPS is expected to shrink by -8.01% this year
84.0 institutions hold shares in Silence Therapeutics Plc ADR (SLN), with institutional investors hold 75.57% of the company’s shares. The shares outstanding are 39.62M, and float is at 37.55M with Short Float at 0.94%. Institutions hold 62.77% of the Float.
The top institutional shareholder in the company is TCG CROSSOVER MANAGEMENT, LLC with over 3.3 million shares valued at $62.61 million. The investor’s holdings represent 7.4962 of the SLN Shares outstanding. As of 2024-06-30, the second largest holder is ARTAL GROUP S.A. with 2.78 million shares valued at $52.81 million to account for 6.323 of the shares outstanding. The other top investors are LOMBARD ODIER ASSET MANAGEMENT (USA) CORP which holds 2.41 million shares representing 5.4731 and valued at over $36.76 million, while REDMILE GROUP, LLC holds 4.5821 of the shares totaling 2.01 million with a market value of $38.27 million.
